CAMBRIDGE, Mass., May 4 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated will webcast its 2006 Annual Meeting of Stockholders on Thursday, May 11, 2006. Joshua Boger, Ph.D., Chairman, President and Chief Executive Officer of Vertex, will host the webcast, which will begin at approximately 9:30 a.m. EDT.
The live webcast may be accessed by visiting the Vertex website at http://www.vrtx.com. A replay of the webcast will also be available on the Company's website until May 25, 2006. To access the webcast, go to Vertex's website and select '2006 Annual Meeting of Stockholders' from the 'Events Calendar.' To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is principally focused on viral diseases, inflammation, autoimmune diseases and cancer. In collaboration with GlaxoSmithKline, Vertex co-promotes the HIV protease inhibitor, Lexiva.
Lexiva is a registered trademark of the GlaxoSmithKline group of companies.
Vertex's press releases are available at http://www.vrtx.com. Vertex Contact: Lora Pike, Manager, Investor Relations, (617) 444-6755
Vertex Pharmaceuticals IncorporatedCONTACT: Lora Pike, Manager, Investor Relations of Vertex PharmaceuticalsIncorporated, +1-617-444-6755
Web site: http://www.vrtx.com//
Company News On-Call: http://www.prnewswire.com/comp/938395.html/
